Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with parkinson's disease

New England Journal of Medicine

Volumn 332, Issue 17, 1995, Pages 1118-1124

  Kordower, Jeffrey H ^a   Freeman, Thomas B ^b   Snow, Barry J ^d   Vingerhoets, François J G ^d   Mufson, Elliott J ^a   Sanberg, Paul R ^b   Hauser, Robert A ^c   Smith, Donald A ^b   Nauert, G Michael ^e   Perl, Daniel P ^f   Olanow, C Warren ^g  

^a St Luke's Medical Center   (United States)

^b Division of Neurosurgery   (United States)

^c Department of Neurology ^*  (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e Tampa Women's Health Center ^*  (Canada)

^f Departments of Pathology and Urology   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMELANIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DOPAMINERGIC TRANSMISSION; FETUS; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOREACTIVITY; MALE; MOTOR PERFORMANCE; NEUROPATHOLOGY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; REINNERVATION;

BRAIN TISSUE TRANSPLANTATION; CASE REPORT; CORPUS STRIATUM; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMAN; MALE; MIDDLE AGE; NEURONS; PARKINSON DISEASE; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0028911848     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199504273321702     Document Type: Article

References (32)

1. Yurek DM, Sladek JR Jr Dopamine cell replacement: Parkinson's disease. Annu Rev Neurosci 1990; 13: 415-440
2. Freed CR, Breeze RE, Rosenberg NL, Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation in Parkinson's disease. N Engl J Med 1992; 327: 1549-1555
3. Lindvall O, Widner H, Rehncrona S, Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 1992; 31: 155-165
4. Freeman TB, Hauser R, Sanberg P, Snow B, Olanow CW Fetal grafting for Parkinson's disease: the Tampa experience. Neurology 1994; 44: A324-A324 abstract.
5. Peschanski M, Defer G, N'Guyen JP, Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994; 117: 487-499
6. Spencer DD, Robbins NJ, Naftolin F, Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992; 327: 1541-1548
7. Henderson BT, Clough CG, Hughes RC, Hitchcock ER, Kenny BG Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch Neurol 1992; 48: 822-827
8. Brundin P, Nilsson OG, Strecker RE, Lindvall O, Astedt B, Bjorklund A Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res 1986; 65: 235-240
9. Redmond DE Jr, Leranth C, Spencer DD, Fetal neural graft survival. Lancet 1990; 336: 820-822
10. Hitchcock EH, Whitwell HL, Sofroniew MV, Bankiewicz KS Survival of TH-positive and neuromelanin-containing cells in patients with Parkinson's disease after intrastriatal grafting of fetal ventral mesencephalon. Exp Neurol 1994; 129: 3-3 abstract.
11. Lindvall O, Brundin P, Widner H, Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990; 247: 574-577
12. Widner H, Tetrud JW, Rehncrona S, Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 1992; 327: 1556-1563
13. Bankiewicz KS, Plunkett RJ, Jacobowitz DM, The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism: histochemical and behavioral studies. J Neurosurg 1990; 72: 231-244
14. Kordower JH, Cochran E, Penn RD, Goetz CG Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann Neurol 1991; 29: 405-412
15. Langston JW, Widner H, Goetz CG, Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7: 2-13
16. Nauert GM, Freeman TB Low-pressure aspiration abortion for obtaining embryonic and early gestational fetal tissue for research purposes. Cell Transplant 1994; 3: 147-151
17. Freeman TB, Kordower JH. Human cadaver embryonic substantia nigra grafts: ontogeny, preoperative graft preparation and tissue storage. In: Lindvall O, Björklund A, Widner H, eds. Intracerebral transplantation in movement disorders. New York: Elsevier Science, 1991:163-70.
18. Vingerhoets FJG, Snow BJ, Schulzer M, Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects. J Nucl Med 1994; 35: 18-24
19. Vingerhoets FJG, Schulzer M, Snow BJ Reproducibility of the fluorodopa PET indices in Parkinson's disease. Mov Disord 1994; 9: Suppl: 119-119 abstract.
20. Kordower JH, Sladek JR Jr, Fiandaca MS, Bing GY, Gash DM Tyrosine hydroxylase-immunoreactive somata within the primate subfornical organ: species specificity. Brain Res 1988; 461: 221-229
21. Graybiel AM Correspondence between the dopamine islands and striosomes of the mammalian striatum. Neuroscience 1984; 13: 1157-1187
22. Graybiel AM, Liu FC, Dunnett SB Intrastriatal grafts derived from fetal striatal primordia. I. Phenotypy and modular organization. J Neurosci 1989; 9: 3250-3271
23. Bjorklund A, Stenevi U Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 1979; 177: 555-560
24. Freed WJ, Perlow MJ, Karoum F, Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies. Ann Neurol 1980; 8: 510-519
25. Freeman TB, Sanberg PR, Nauert GM, The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant 1995; 4: 141-154
26. Freeman TB, Spence MS, Boss BD, Development of dopaminergic neurons in the human substantia nigra. Exp Neurol 1991; 113: 344-353
27. Verney C, Zecevic N, Nikolic B, Alvarez C, Berger B Early evidence of catecholaminergic cell groups in 5- and 6-week-old human embryos using tyrosine hydroxylase and dopamine-beta-hydroxylase immunocytochemistry. Neurosci Lett 1991; 131: 121-124
28. Collier TJ, Gallagher MJ, Sladek CD Cryopreservation and storage of embryonic rat mesencephalic dopamine neurons for one year: comparison to fresh tissue in culture and neural grafts. Brain Res 1993; 623: 249-256
29. Nicholas MK, Antel JP, Stefansson K, Arnason BG Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol 1987; 139: 2275-2283
30. Duan WM, Widner H, Bjorklund A, Brundin P Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected? Neuroscience 1993; 57: 261-274
31. Rosenstein JM Neocortical transplants in the mammalian brain lack a blood-brain barrier to macromolecules. Science 1988; 235: 772-774
32. Bertram KJ, Shipley MT, Ennis M, Sanberg PR, Norman AB Permeability of the blood-brain barrier within rat intrastriatal transplants assessed by simultaneous systemic injection of horseradish peroxidase and Evans blue dye. Exp Neurol 1994; 127: 245-252